Ticker Hub
RGNX — AI Analysis & Sentiment
4 recent AI-generated analyses for RGNX. Sentiment and confidence insights updated continuously.
STEPHEN PAKOLA OVERSAW RGX-111 SAFETY CLAIMS THAT COST RGNX INVESTORS MILLIONS: SUEWALLST
REGENXBIO faces increased legal and reputational risk with an executive named in a securities lawsuit, potentially signaling deeper issues with RGX...
Mar 12, 2026REGENXBIO Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
REGENXBIO's financial results and operational updates reveal multiple catalysts in 2026, including pivotal trial data and regulatory milestones.
Mar 5, 2026REGENXBIO Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - RGNX
REGENXBIO faces significant legal and financial risks from an ongoing securities class action lawsuit alleging misrepresentation regarding its RGX-...
Feb 20, 2026Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the REGENXBIO, Inc. Securities Class Action Lawsuit
Regenxbio faces a securities class action lawsuit following an FDA clinical hold on its RGX-111 program. This significantly increases legal and fin...
Feb 17, 2026